Heat Biologics CEO Jeff Wolf talks with Contagion about the firm’s effort to develop a vaccine for the coronavirus focused on combining antibody and T cell immunity using the GP-96 protein. “We have a very unique vaccine,” Wolf claims, pointing…
Heat Biologics CEO Jeff Wolf talks with Contagion about the firm’s effort to develop a vaccine for the coronavirus focused on combining antibody and T cell immunity using the GP-96 protein. “We have a very unique vaccine,” Wolf claims, pointing…
Today on The Babylon Bee Podcast, Kyle and Ethan talk to Dr. David Fisher, one of The Babylon Bee’s longest-tenured writers going back to the Adam Ford days when The Bee was still funny. They talk about the politics and…
Armand Balboni, MD, PhD, JD, CEO of Appili Therapeutics, discusses progress toward FDA authorization and/or approval of favipiravir for COVID-19.